C

CSL

Develops and delivers biotherapies and vaccines

Head of Global Labelling

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeNo salary listedIn-person

About the Job

Requirements

  • Significant experience in Global Regulatory Affairs, with a strong focus on product labelling and management of core labelling documentation.
  • Proven leadership of global, multi-country teams, including coaching and developing talent.
  • Track record owning and continuously improving a regulated process end-to-end.
  • Experience representing a company's positions to governance bodies or external regulators.
  • Working familiarity with labelling-related audits and the regulatory frameworks that govern labelling compliance.
  • Director-level experience or equivalent in a global pharma or biotech organization.

Responsibilities

  • Lead a global team of established labelling professionals, coaching them in strategic thinking and expected leadership behaviours.
  • Own the end-to-end labelling review and approval process and drive its continuous improvement.
  • Set global labelling strategy, balancing business needs with accurate benefit/risk information for end users.
  • Ensure processes deliver accurate, timely labelling information supporting the safe and effective use of products, including timely safety-related updates.
  • Ensure efficient labelling operations support time-critical annual strain updates for seasonal influenza vaccines.
  • Provide labelling perspective to governance bodies and represent the company in external regulatory forums.
  • Provide labelling subject matter expertise for internal and external labelling-related audits.
  • Work with Global Safety, Clinical Development, Commercial, and Supply Chain stakeholders to ensure effective and timely labelling deliverables across regions.

About the Company

CSL

Develops and delivers biotherapies and vaccines

CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Parkville, Australia
Founded
1916

Recently Posted Jobs

Explore more opportunities at CSL

See more jobs